FIELD: medicine; pharmaceutics.
SUBSTANCE: invention refers to an oral dosage form of a capsule formulation effective against VV (variola virus) and other human and animal pathogenic orthopoxviruses, and can be used in pharmaceutics, virology, medicine and veterinary science. Ready dosage form contains as an active compound having anti-orthopoxvirus activity 7-[N-(4-trifluoromethylbenzoyl)-hydrazinocarbonyl]-tricyclo[3.2.2.02,4]non-8-ene-6-carboxylic acid (NIOH-14), lactose monohydrate, amorphous silicon dioxide anhydrous (aerosil), magnesium stearate and microcrystalline cellulose (MCC), potato starch, sodium chloride and purified water in the amounts specified in the claim.
EFFECT: technical result of the invention consists in expanding the range of ready dosage forms used in medicine and veterinary science for treating and preventing orthopoxvirus-mediated diseases.
1 cl, 2 dwg, 4 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICATED PRODUCT FOR SMALLPOX VIRUS AND METHOD FOR PRODUCING AND USING IT | 2013 |
|
RU2543338C1 |
1-HYDROXY- AND 1-METHOXY-2-(4-NITROPHENYL)IMIDAZOLE DERIVATIVES WITH ANTIVIRAL ACTIVITY AGAINST ORTHOPOXVIRUSES | 2022 |
|
RU2794763C1 |
METHOD FOR DETERMINING CONCENTRATION OF ANTIVIRAL DRUGS IN BIOMATERIALS OF LABORATORY ANIMALS | 2020 |
|
RU2748249C1 |
METHOD OF ASSESSMENT OF ACTIVITY OF MEDICAL AND PREVENTIVE DRUGS AGAINST SMALLPOX VIRUS | 2014 |
|
RU2565812C1 |
METHOD OF ASSESSMENT OF ACTIVITY OF THERAPEUTIC AND PROPHYLACTIC PREPARATIONS AGAINST NATURAL SMALLPOX VIRUS | 2013 |
|
RU2522483C1 |
AGENT FOR ARRESTING UNDESIRABLE VACCINAL REACTIONS AND COMPLICATIONS DURING PRIMARY VACCINATION WITH VARIOLAR VACCINES AND METHOD FOR USE THEREOF | 2013 |
|
RU2542490C1 |
METHOD FOR ASSESSING ANTISMALLPOX ACTIVITY OF THERAPEUTIC PREPARATIONS | 2012 |
|
RU2496149C1 |
SMALLPOX VIRAL STRAIN GPA FOR STUDYING EFFICACY OF ANTIVIRAL PREPARATIONS in vivo AND ASSESSING REDUCTION ROUTINES UNDESIRED VACCINE REACTIONS ACCOMPANYING PRIMARY SMALLPOX VACCINATION | 2013 |
|
RU2542400C1 |
METHOD OF EVALUATION OF ANTIVARIOLIC ACTIVITY OF THERAPEUTIC AND PROPHYLACTIC PREPARATIONS | 2013 |
|
RU2526504C1 |
AMIDES CONTAINING ADAMANTANE AND AROMATIC MOIETIES USED AS INHIBITORS OF ORTHOPOXVIRUS REPRODUCTION | 2021 |
|
RU2798665C2 |
Authors
Dates
2020-03-16—Published
2019-08-20—Filed